<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> is the precursor lesion for esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, resulting from prolonged <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The influence of the efficacy of reflux control on the development of neoplastic change in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined esophagus</z:e> is not established </plain></SENT>
<SENT sid="2" pm="."><plain>This study compares the rate of development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in patients with columnar <z:mpath ids='MPATH_160'>metaplasia</z:mpath> of the esophagus between patients treated pharmacologically and those treated with antireflux surgery </plain></SENT>
<SENT sid="3" pm="."><plain>This study is a retrospective review of a cohort of patients enrolled in a multicenter national registry involving 738 patients from seven UK centers </plain></SENT>
<SENT sid="4" pm="."><plain>Forty-one were treated with antireflux surgery, 42 with <z:chebi fb="0" ids="37961">H2 receptor antagonist</z:chebi>, 532 with <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi>, and 114 with a combination of these medications </plain></SENT>
<SENT sid="5" pm="."><plain>Nine had none of these medications or surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Total follow-up was 3697 years </plain></SENT>
<SENT sid="7" pm="."><plain>Mean age and follow-up for patients treated medically were 61.6 and 4.96 years and surgically were 50.5 and 6.19 years, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>No patient in the surgical group developed high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty patients treated medically developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and 10 developed HGD </plain></SENT>
<SENT sid="10" pm="."><plain>Hazards ratio comparing pharmacological to surgical therapy for development of <z:hpo ids='HP_0000001'>all</z:hpo> grades of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> 1.77 (P = 0.272) </plain></SENT>
<SENT sid="11" pm="."><plain>Log rank test comparing antireflux surgery to pharmacological therapy for development of HGD or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> P = 0.1287 and for <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> P = 0.2125 </plain></SENT>
<SENT sid="12" pm="."><plain>Although there was a trend towards greater efficacy of antireflux surgery over pharmacological therapy in reducing the development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, this did not reach statistical significance </plain></SENT>
</text></document>